ライフサイエンスコーパス: diffusion-weighted imaging

1 asrecently identifiedin these patients using diffusion weighted imaging.

2 were assessed by brain MRI at 3 T including diffusion weighted imaging.

3 in white matter organization as measured by diffusion-weighted imaging.

4 te functional magnetic resonance imaging and diffusion-weighted imaging.

5 onths after intracerebral haemorrhage) using diffusion-weighted imaging.

6 arent diffusion coefficients (ADCs) using MR diffusion-weighted imaging.

7 of tests of executive function and underwent diffusion-weighted imaging.

8 ery territory, lesion volume was measured by diffusion-weighted imaging.

9 netic susceptibility contrast agent; and (b) diffusion-weighted imaging.

10 ocal epilepsy, using fixel-based analysis of diffusion-weighted imaging.

11 dence interval: 0.86, 0.99) at axial oblique diffusion-weighted imaging.

12 ted, dynamic contrast material-enhanced, and diffusion-weighted imaging.

13 Anatomical connectivity was examined using diffusion-weighted imaging.

14 baseline, post procedure, and 6 months using diffusion-weighted imaging.

15 d T2-weighted, dynamic contrast-enhanced and diffusion-weighted imaging (1.5 T, pelvic phased-array c

16 patients to predict the final infarction at diffusion-weighted imaging 24 hours after CT perfusion.

17 Lesion percentage CNRs were 77% for diffusion-weighted imaging, 5.5% for CT, 9.8% for T2-wei

18 Among patients with available diffusion-weighted imaging, 6 patients (40%) did not sho

19 ral imaging (T2-weighted turbo spin-echo and diffusion-weighted imaging), acquired within 8 minutes 4

20 e evidence that lesion volumes determined by diffusion-weighted imaging acutely may be predictive of

21 nal Institutes of Health Stroke Scale score, diffusion-weighted imaging Alberta Stroke Program Early

22 roke Scale score, 15 vs 17 [P = .03]; median diffusion-weighted imaging Alberta Stroke Program Early

23 g proton magnetic resonance spectroscopy and diffusion weighted imaging also provide useful informati

24 Diffusion-weighted imaging, anatomic MR imaging, and bio

25 e performed an extended series of multishell diffusion-weighted imaging and other structural imaging

26 AA] to creatine [Cr], and lactate to Cr) and diffusion-weighted imaging and perfusion-weighted imagin

27 arious spelling tests and magnetic resonance diffusion-weighted imaging and perfusion-weighted imagin

28 Some of these techniques, including diffusion-weighted imaging and perfusion-weighted imagin

29 motor system to the cerebral peduncle using diffusion-weighted imaging and probabilistic tractograph

30 ents without LVH (HTN non-LVH) using cardiac diffusion-weighted imaging and T1 mapping.

31 +/- 3.08 years) with 3.0 T MRI using cardiac diffusion-weighted imaging and T1 mapping.

32 ghted imaging alone and then, 4 weeks later, diffusion-weighted imaging and T2-weighted imaging toget

33 algorithm to identify the VOF in vivo using diffusion-weighted imaging and tractography, and show th

34 l study to measure white-matter development (diffusion-weighted imaging) and reading development (beh

35 that exhibited GCI-induced hyperintensity in diffusion-weighted imaging, and a significant reduction

36 bjects underwent spinal MR imaging including diffusion-weighted imaging, and bone marrow ADCs were ca

37 provides an overview of liver MRI protocol, diffusion-weighted imaging, and contrast agents.

38 postcontrast T1-weighted), conventional with diffusion-weighted imaging, and conventional with diffus

39 ighted sequences), MR spectroscopic imaging, diffusion-weighted imaging, and dynamic contrast agent-e

40 c MR imaging, including T2-weighted imaging, diffusion-weighted imaging, and dynamic contrast materia

41 MR imaging, susceptibility-weighted imaging, diffusion-weighted imaging, and higher order diffusion i

42 chemic attack or seizure, no acute lesion on diffusion-weighted imaging, and no clinical or electroen

43 -weighted fast spin-echo imaging; unenhanced diffusion-weighted imaging; and-before and after gadolin

44 interval, 2.9-4.2) greater lesion volume on diffusion-weighted imaging as compared with INR of 2.0 o

45 imaging features with a special emphasis on diffusion-weighted imaging, as diffusion sequences may h

46 lution structural imaging in several planes, diffusion-weighted imaging at 0, 800, 1000, and 1400 mm(

47 hose without mismatch between perfusion- and diffusion-weighted imaging at baseline.

48 l magnetic resonance (MR) imaging, including diffusion-weighted imaging, before nephrectomy were incl

49 Then, using structural (diffusion-weighted imaging) brain imaging techniques, we

50 ors that are indistinguishable using in vivo diffusion-weighted imaging, but may be related to reduce

51 Diffusion weighted imaging can help in the distinction b

52 We found that MT and diffusion-weighted imaging can detect histological chang

53 y can detect striatal hyperechogenicity, and diffusion-weighted imaging can detect increased putamen

54 Diffusion-weighted imaging caused underestimation of the

55 ntratubular flow all play important roles in diffusion-weighted imaging contrast.

56 Diffusion-weighted imaging coupled with tractography is

57 HO, RECIST), enhancement (EASL, mRECIST) and diffusion-weighted imaging criteria (apparent diffusion

58 abilistic tractography on magnetic resonance diffusion weighted imaging data to segment basal ganglia

59 Diffusion-weighted imaging data of 12 treatment-naive pa

60 Diffusion-weighted imaging data were acquired for 84 of

61 High-angular resolution diffusion-weighted imaging data were used to conduct who

62 The diffusion weighted imaging demonstrated restricted diffu

63 T1-weighted TSE and single-shot echo-planar diffusion-weighted imaging-derived ADC mapping.

64 Purpose To compare single-shot echo-planar diffusion-weighted imaging-derived apparent diffusion co

65 Perfusion weighted imaging (PWI) and diffusion weighted imaging (DWI) allow for more detailed

66 To evaluate the role of diffusion weighted imaging (DWI) and apparent diffusion

67 troke symptoms, with MRI sequences including diffusion weighted imaging (DWI) and perfusion weighted

68 Multislice diffusion weighted imaging (DWI) and single-slice dynami

69 Remarkably, 3D diffusion weighted imaging (DWI) delivered unprecedented

70 rly (i.e. observed within 2 h) reductions in diffusion weighted imaging (DWI) intensity following tre

71 Though diffusion weighted imaging (DWI) is frequently used for

72 The volume and number of diffusion weighted imaging (DWI) positive/apparent diffu

73 Resting-state (rs)-fMRI and diffusion weighted imaging (DWI) scans were undertaken b

74 Diffusion weighted imaging (DWI) studies in humans have

75 we use magnetic resonance imaging (MRI) and diffusion weighted imaging (DWI) to identify the brain s

76 this study was to investigate the utility of diffusion weighted imaging (DWI) using Apparent Diffusio

77 In rats, quantitative diffusion weighted imaging (DWI), perfusion weighted ima

78 ce imaging (MRI), MR spectroscopy (MRS), and diffusion weighted imaging (DWI), was used in rats expos

79 The evolution of the lesion was monitored by diffusion weighted imaging (DWI).

80 ith breath hold (BH) and free breathing (FB) diffusion weighted imaging (DWI).

81 A study was undertaken to determine whether diffusion-weighted imaging (DWI) abnormalities in normal

82 were scanned with a 3-T MR imager, including diffusion-weighted imaging (DWI) and DCE MR imaging.

83 ied to Crohn's disease assessment, including diffusion-weighted imaging (DWI) and magnetization trans

84 Diffusion-weighted imaging (DWI) and perfusion-weighted

85 he feasibility and diagnostic performance of diffusion-weighted imaging (DWI) applied to the whole bo

86 suggested that multiple ischemic lesions on diffusion-weighted imaging (DWI) are common in acute str

87 Brain lesions on diffusion-weighted imaging (DWI) are frequently found af

88 Diffusion-weighted imaging (DWI) detects small changes i

89 y aimed to evaluate the application value of diffusion-weighted imaging (DWI) for assessing paradoxic

90 To evaluate the value of diffusion-weighted imaging (DWI) for distinguishing betw

91 Diffusion-weighted imaging (DWI) has been at the forefro

92 Diffusion-weighted imaging (DWI) has emerged as the most

93 tudy was to assess the diagnostic benefit of diffusion-weighted imaging (DWI) in an (18)F-FDG PET/MR

94 ine the frequency of acute brain infarcts on diffusion-weighted imaging (DWI) in patients with monocu

95 icacy of intravoxel incoherent motion (IVIM) diffusion-weighted imaging (DWI) in the grading of gliom

96 Diffusion-weighted imaging (DWI) is an MRI modality usin

97 Interestingly, although diffusion-weighted imaging (DWI) is more frequently used

98 Magnetic resonance (MR) diffusion-weighted imaging (DWI) is sensitive to small a

99 Purpose To correlate quantitative diffusion-weighted imaging (DWI) parameters derived from

100 cognitive deficits, we used a comprehensive diffusion-weighted imaging (DWI) protocol and characteri

101 Diffusion-weighted imaging (DWI) provides evidence of ac

102 sions upgraded from category 3 to 4 based on diffusion-weighted imaging (DWI) score of 5; and 71.7%-7

103 se To determine the usefulness of whole-body diffusion-weighted imaging (DWI) to assess the response

104 We used high angular resolution diffusion-weighted imaging (DWI) to evaluate the structu

105 Here we used diffusion-weighted imaging (DWI) tractography to show th

106 anisotropy are greatest, can be studied with diffusion-weighted imaging (DWI) tractography.

107 iffusion that is found on magnetic resonance diffusion-weighted imaging (DWI) typically indicates acu

108 of coregistered pretreatment CTP and 24-hour diffusion-weighted imaging (DWI) was then undertaken to

109 At baseline, ischemic lesions on diffusion-weighted imaging (DWI) were found in 35% of pa

110 sisting of magnetic resonance imaging (MRI), diffusion-weighted imaging (DWI), and 1,356 large-format

111 fluid-attenuated inversion recovery (FLAIR), diffusion-weighted imaging (DWI), and perfusion and func

112 ith 39 HCC lesions underwent mpMRI including diffusion-weighted imaging (DWI), blood-oxygenation-leve

113 echnique for identifying fiber pathways from diffusion-weighted imaging (DWI), was used to reconstruc

114 Using diffusion-weighted imaging (DWI), we failed to demonstra

115 ng (1H-MRSI), T2-weighted imaging (T2WI) and diffusion-weighted imaging (DWI).

116 tumor assessment and to compare it with 7-T diffusion-weighted imaging (DWI).

117 Diffusion-weighted imaging enabled measurement of early

118 At 7 T, one DW diffusion-weighted imaging examination of less than 4 mi

119 atients with mismatch between perfusion- and diffusion-weighted imaging findings at baseline who expe

120 ng whole-body morphologic MRI augmented with diffusion-weighted imaging for both staging and response

121 ant parameters corresponding to the score of diffusion-weighted imaging for peripheral zone lesions a

122 stic tractography on high angular resolution diffusion-weighted imaging (HARDI), we reconstructed pat

123 Diffusion-weighted imaging has become increasingly impor

124 tector 64-slice computed tomography (CT) and diffusion-weighted imaging has enabled higher-resolution

125 amage with magnetic resonance perfusion- and diffusion-weighted imaging immediately after stroke in 8

126 Diffusion weighted imaging in Patient S.P. and controls

127 Use of diffusion-weighted imaging in addition to T2-weighted im

128 rity and outcome, and may support a role for diffusion-weighted imaging in the assessment of acute st

129 Diffusion-weighted imaging in the basal ganglia may prov

130 s may help explain some of this variance, as diffusion weighted imaging is sensitive to the white mat

131 Diffusion-weighted imaging is a noninvasive technique th

132 erate to substantial for features related to diffusion-weighted imaging (kappa = 0.535-0.619); fair t

133 t effect on clinical outcome despite reduced diffusion-weighted imaging lesion growth during therapy.

134 it (LTB) or uncertain to benefit (UTB) using diffusion-weighted imaging lesion volume and clinical cr

135 Mean diffusion-weighted imaging lesion volume at baseline was

136 For regions defined as infarct core (diffusion-weighted imaging lesion) and presumed penumbra

137 ury, as indicated by the reappearance of the diffusion-weighted imaging lesion, has recently been doc

138 Large diffusion-weighted imaging lesions and a corresponding f

139 The score was associated with small, acute, diffusion-weighted imaging lesions and posterior white m

140 Diffusion-weighted imaging lesions contribute to the ove

141 The prevalence of diffusion-weighted imaging lesions was 9/39 (23%) in pro

142 th intracerebral haemorrhage (P = 0.024); no diffusion-weighted imaging lesions were found in control

143 Diffusion-weighted imaging lesions were mainly cortical

144 We investigated associations between diffusion-weighted imaging lesions, clinical and radiolo

145 Also, lesions seen with diffusion-weighted imaging may be reversible as a result

146 d gray matter volume (NWMV and NGMV) and the diffusion-weighted imaging measure of WB mean parenchyma

147 and network efficiency were assessed through diffusion-weighted imaging, measuring fractional anisotr

148 schaemic brain injury on magnetic reasonance diffusion-weighted imaging (MR DWI) could provide additi

149 and included T2-weighted imaging (n = 104), diffusion-weighted imaging (n = 88), dynamic contrast-en

150 5, after adjusting for ABCD2 score, positive diffusion-weighted imaging (odds ratio [OR] 3.8, 95% CI

151 (n = 24, age = 27.4 +/- 6.3 years) underwent diffusion weighted imaging of the brain.

152 Diffusion-weighted imaging of transplanted kidneys is te

153 All underwent diffusion-weighted imaging on admission.

154 ion warfarin use who had INR measurement and diffusion-weighted imaging performed within 24 hours of

155 High-resolution diffusion-weighted imaging, performed within 48 hours af

156 t with the advent of chemical shift imaging, diffusion-weighted imaging, perfusion imaging and MR spe

157 acute left hemisphere stroke symptoms, with diffusion-weighted imaging, perfusion-weighted imaging,

158 Despite these caveats, diffusion-weighted imaging-perfusion-weighted imaging re

159 Advances in MRI acquisitions including diffusion-weighted imaging, post-acquisition image proce

160 ker, apparent diffusion coefficient (ADC) on diffusion-weighted imaging, predicted which fetuses will

161 In diffusion-weighted imaging protocols where the signal at

162 onsisting of only transverse T2-weighted and diffusion-weighted imaging pulse sequences compared with

163 Diffusion-weighted imaging quantified using the mono-exp

164 s inversely correlated with lesion volume on diffusion-weighted imaging (r = -0.38).

165 ons relating acute lesion volume measured by diffusion-weighted imaging (r = 0.61) and chronic lesion

166 transcranial sonography, magnetic resonance diffusion-weighted imaging regional apparent diffusion c

167 usion, and magnetic resonance perfusion- and diffusion-weighted imaging, respectively.

168 Diffusion weighted imaging revealed differences in white

169 U underwent multimodal T1 volumetric MRI and diffusion weighted imaging scans.

170 than fluid-attenuated inversion recovery or diffusion-weighted imaging scores (area under the receiv

171 ct early suspected PML using MRI including a diffusion-weighted imaging sequence.

172 n neuroimaging (computed tomographic scan or diffusion-weighted imaging sequences on magnetic resonan

173 s on fluid-attenuated inversion recovery and diffusion-weighted imaging sequences predominantly invol

174 with fluid-attenuated inversion recovery and diffusion-weighted imaging sequences were analyzed by us

175 nt-echo sequences were interspersed with two diffusion-weighted imaging series.

176 We used diffusion-weighted imaging to investigate whether indivi

177 al MR imaging pattern by adding quantitative diffusion-weighted imaging to standard MR imaging protoc

178 In overall tumor detection, addition of diffusion-weighted imaging to T2-weighted imaging improv

179 on-tensor imaging may be more sensitive than diffusion-weighted imaging to white matter ischemia.

180 (Gd-enhanced lesion length); and (iv) brain diffusion-weighted imaging (to derive optic radiation fr

181 ional magnetic resonance imaging at rest and diffusion-weighted imaging tractography.

182 on-density-weighted MR imaging (P < .002 for diffusion-weighted imaging vs others).

183 The pattern of AChA involvement on initial diffusion-weighted imaging was dichotomised as spared or

184 In all patients, bilateral DW diffusion-weighted imaging was performed in 3 minutes 35

185 Diffusion-weighted imaging was performed in 40 subjects

186 ts hospitalized in a 10-month period in whom diffusion-weighted imaging was performed within 6 hours

187 etic resonance (MR) imaging (T1-weighted and diffusion-weighted imaging) was performed with a 3-T MR

188 Using a combination of EEG, fMRI, and diffusion-weighted imaging, we show that activity in the

189 structural connectivity, as measured through diffusion-weighted imaging, we were able to predict func

190 te functional magnetic resonance imaging and diffusion-weighted imaging were performed in 35 particip

191 Serial diffusion-weighted imaging were performed on 79% gestati

192 T1-weighted and diffusion-weighted imaging were performed, and volume an

193 Here, we use diffusion weighted imaging with probabilistic tractograp

194 Combining high-resolution diffusion weighted imaging with resting-state fMRI, we p

195 (MR) imaging before and after CRT, including diffusion-weighted imaging with 34 b values prior to sur

196 S and six healthy control subjects underwent diffusion-weighted imaging with a range of diffusion wei

197 Diffusion-weighted imaging with ADC mapping is not suffi

198 DW diffusion-weighted imaging with combined parallel imagin

199 ulated factor of seven when compared with DW diffusion-weighted imaging with ss-EPI single-shot echo-

200 We then used diffusion-weighted imaging with tractography to assess w